Purchase Order 75N91018P00576

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for an Oncomine Comprehensive Manual Combo Kit (catalog A35805) valued at $17,100.00 on August 7, 2018, with completion by September 30, 2018. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for an Oncomine Comprehensive Manual Combo Kit valued at $13,295.68 on April 2, 2019, with completion scheduled for May 1, 2019. Place of performance is Carlsbad, California. The order carries firm fixed price and no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $17,100 on December 19, 2018, for an Oncomine Comprehensive V3M Combo Kit (catalog# A35805), with ultimate completion on January 31, 2019. Place of performance is Grand Island, New York. Life Technologies is a wholly owned subsidiary of Thermo Fisher Scientific and competes without small-business certifications. The order carries firm fixed-price pricing with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for Ion Library Quantitation Kit consumables, catalog A26121, valued at $16,707.76 on May 29, 2018, with completion by July 1, 2018. Place of performance is Bethesda, Maryland. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $8,120.00 on July 3, 2018, for one ION AMPLISEQ LIB KIT 2.0 (catalog A26120). Performance is at Bethesda, Maryland. The order carries firm fixed pricing and completed July 31, 2018. No set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $13,879.50 in biological kits, with an award date of June 13, 2019 and completion date of July 13, 2019. Place of performance is Carlsbad, California. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for ION 540 chip kits at $13,504.05 on April 2, 2019, with completion due May 2, 2019. Performance occurs at the vendor's Carlsbad, California facility. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $5,611.84 on July 11, 2017, with ultimate completion on August 16, 2018. No set-aside was used. Performance occurs in Bethesda, Maryland. The order is for laboratory instrumentation, reagents, consumables, or maintenance services typical of Life Technologies' federal portfolio in life-sciences research and diagnostic infrastructure. Pricing is firm fixed price.</p>